By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today completed its acquisition of Caliper Life Sciences for $10.50 per share, valuing the deal at around $600 million.

The purchase, announced in September, provides PerkinElmer with Caliper's portfolio of imaging, microfluidics, automation, and sample preparation platforms and technologies and is expected to extend PerkinElmer's reach into the life sciences research space.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.